Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,933.53 825.08 203.88 -198.21 33.60 0.00 18.4506 -0.38 -1.0245 -21.2826 -0.09 -0.09 7.5115 - -
Maximum - - - - - - 465,034.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Cytokinetics, Incorporated CYTK 56.19 -2.43 -4.15% 1,032 vs. 1,187 6,631.00 0.00 -135.00 -127.00 -2,247.00 -1.3300 -13.7171 0.0000 -1.7916 -162.4467 0.3424 -0.1679 6.9796 118.00
Structure Therapeutics Inc. GPCR 36.97 -1.73 -4.47% 724 vs. 672 2,114.00 0.00 -26.00 -34.00 -232.00 -0.5600 -18.2892 0.0000 0.0000 0.0000 -0.0606 -0.0569 18.5046 57.00
Crinetics Pharmaceuticals, Inc. CRNX 58.78 -1.23 -2.05% 916 vs. 662 5,292.00 0.00 -66.00 -54.00 -720.00 -0.9300 -12.5639 0.0000 0.2594 -104.5781 -0.0765 -0.0684 17.5865 90.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for CRNX and its peers to uncover potential buy and sell opportunities.